Our Insight
The articles below are published as a service to our clients and friends. They should be viewed only as a summary of the law and not as a substitute for legal consultation in a particular case. We encourage you to contact us to discuss your specific situation.
Over the past several decades, pharmaceutical companies have emerged as favored targets for securities class actions. As a result of that trend, the stakes are high for D&O insurers as well ...
The D&O claims environment is now in an unusually uncertain state. Record high inflation, interest rate increases, supply chain disruptions, tight labor market, the collapse of several large ...
Taxpayers whose property tax valuation was affected by the COVID-19 pandemic have a unique but limited opportunity to challenge their valuation. Senate Bill 57 was signed into law on April 27 by ...
This month's Client Alert asks Delaware-incorporated companies to be on the lookout for formal invitations to enter into Delaware's Voluntary Disclosure Program ("VDA Program"). The failure to ...
Estate plans should be all-encompassing. This can include cars, homes, stocks and even digital assets. But another thing estate owners should consider is their beneficiaries, especially if they ...
Safe Harbor for Borrowers Who Received PPP Loans in Principal Amount Less than $2 Million